309 related articles for article (PubMed ID: 33598509)
21. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
22. Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells.
Huang C; Deng W; Xu HZ; Zhou C; Zhang F; Chen J; Bao Q; Zhou X; Liu M; Li J; Liu C
Comput Struct Biotechnol J; 2023; 21():1606-1620. PubMed ID: 36874158
[TBL] [Abstract][Full Text] [Related]
23. Glucose availability is a decisive factor for Nrf2-mediated gene expression.
Heiss EH; Schachner D; Zimmermann K; Dirsch VM
Redox Biol; 2013; 1(1):359-65. PubMed ID: 24024172
[TBL] [Abstract][Full Text] [Related]
24. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
[TBL] [Abstract][Full Text] [Related]
26. Role of microRNAs in the regulation of breast cancer stem cells.
Liu S; Clouthier SG; Wicha MS
J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
[TBL] [Abstract][Full Text] [Related]
27. Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
Gao C; Shen Y; Jin F; Miao Y; Qiu X
PLoS One; 2016; 11(5):e0154576. PubMed ID: 27167619
[TBL] [Abstract][Full Text] [Related]
28. Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism.
Cho ES; Kim NH; Yun JS; Cho SB; Kim HS; Yook JI
Cells; 2020 Sep; 9(9):. PubMed ID: 32927665
[TBL] [Abstract][Full Text] [Related]
29. Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells.
Peng M; Huang Y; Zhang L; Zhao X; Hou Y
Front Oncol; 2022; 12():899502. PubMed ID: 35574326
[TBL] [Abstract][Full Text] [Related]
30. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4).
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Cancers (Basel); 2018 Jan; 10(2):. PubMed ID: 29385093
[TBL] [Abstract][Full Text] [Related]
32. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
34. Sustained oxidative stress instigates differentiation of cancer stem cells into tumor endothelial cells: Pentose phosphate pathway, reactive oxygen species and autophagy crosstalk.
Movahed ZG; Yarani R; Mohammadi P; Mansouri K
Biomed Pharmacother; 2021 Jul; 139():111643. PubMed ID: 33945913
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.
Biddle A; Liang X; Gammon L; Fazil B; Harper LJ; Emich H; Costea DE; Mackenzie IC
Cancer Res; 2011 Aug; 71(15):5317-26. PubMed ID: 21685475
[TBL] [Abstract][Full Text] [Related]
36. FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells.
Choi HJ; Jhe YL; Kim J; Lim JY; Lee JE; Shin MK; Cheong JH
Redox Biol; 2020 Sep; 36():101589. PubMed ID: 32521504
[TBL] [Abstract][Full Text] [Related]
37. Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer.
Ishiwata T
Pathol Int; 2016 Nov; 66(11):601-608. PubMed ID: 27510923
[TBL] [Abstract][Full Text] [Related]
38. Nonhormonal therapy for endometriosis based on energy metabolism regulation.
Kobayashi H; Shigetomi H; Imanaka S
Reprod Fertil; 2021 Dec; 2(4):C42-C57. PubMed ID: 35118411
[TBL] [Abstract][Full Text] [Related]
39. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.
Dong C; Yuan T; Wu Y; Wang Y; Fan TW; Miriyala S; Lin Y; Yao J; Shi J; Kang T; Lorkiewicz P; St Clair D; Hung MC; Evers BM; Zhou BP
Cancer Cell; 2013 Mar; 23(3):316-31. PubMed ID: 23453623
[TBL] [Abstract][Full Text] [Related]
40. SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells.
Yasui K; Shimamura M; Mitsutake N; Nagayama Y
Thyroid; 2013 Aug; 23(8):989-96. PubMed ID: 23432420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
